The healthcare data platform developer has raised new funding from the six investors in its last round, including Merck Global Health Innovation Fund.
Pharmaceutical firm Merck & Co has invested in US-based cloud healthcare software developer ClearData as part of a $12m round, participating through its Merck Global Health Innovation Fund.
Norwest Venture Partners (NVP), Excel Venture Management, Heritage Group, HLM Venture Partners and Flare Capital Partners also contributed capital, the round’s six backers all having invested in ClearData’s $25m series C round in mid-2015.
Founded in 2009, ClearData has built a secure cloud software platform for healthcare data that is used…
